Director, Precision Pathology Biobanking Center at Memorial Sloan Kettering Cancer Center
Michael Roehrl M.D., Ph.D., is Director of the Precision Pathology Biobanking Center at Memorial Sloan Kettering Cancer Center, New York, USA. He is dually board-certified in Pathology and Laboratory Medicine. He holds an MD from the Technical University of Munich, a Ph.D. in Biological Chemistry from Harvard University, and trained clinically at Massachusetts General Hospital in Boston. Michael Roehrl was previously Director of the UHN Program in BioSpecimen Sciences and Associate Professor of Pathology and Laboratory Medicine at the University of Toronto.
His main scientific expertise is related to the discovery and development of new molecular diagnostics for colorectal and pancreatic cancers.
Title: Big Data and AI in Science-Driven Biobanking: The Next Frontier
- Pathology as the central academic discipline of science-driven biobanking
- AI and Natural Language Processing for Big Data annotation
- Developing next generation diagnostics and companion assays for clinical trials and drug development
- Proteomics as the “post-genomic revolution”